Rapacuronium: an alternative to succinylcholine for electroconvulsive therapy.
Kadar
A G
AG
Department of Anesthesiology, Cedars Sinai Medical Center, Los Angeles, California, USA.
Kramer
B A
BA
Barth
M C
MC
White
P F
PF
D003866:Depressive Disorder / Q000628:therapy; D004198:Disease Susceptibility; D004565:Electroconvulsive Therapy; D006801:Humans; D008297:Male; D008305:Malignant Hyperthermia / Q000209:etiology / Q000517:prevention & control*; D008875:Middle Aged; D009467:Neuromuscular Depolarizing Agents / Q000009:adverse effects*; D003473:Neuromuscular Nondepolarizing Agents; D013390:Succinylcholine / Q000009:adverse effects*; D014673:Vecuronium Bromide / Q000031:analogs & derivatives*
D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents; D014673:Vecuronium Bromide; C082938:rapacuronium; D013390:Succinylcholine